# MainStreet Bancshares, Inc.: financial statements, quarterly

MNSB · Nasdaq · CIK 1693577 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/mnsb.md) · [Financials](/companies/mnsb/financials.md) · [Filings](/companies/mnsb/filings.md) · [Insiders](/companies/mnsb/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/mnsb/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [0.5](/filings/0001437749-24-034841.md) | [0.5 d](/filings/0001437749-26-008073.md) | [0.5](/filings/0001437749-25-015691.md) | [0.5](/filings/0001437749-25-025595.md) | [0.6](/filings/0001437749-25-033742.md) | [0.5 d](/filings/0001437749-26-008073.md) | [0.5](/filings/0001437749-26-015780.md) | [0.5](/filings/0001437749-26-026460.md) | [0.6](/filings/0001437749-25-033742.md) | [0.6 d](/filings/0001437749-26-008073.md) | [0.6](/filings/0001437749-26-015780.md) | [0.6](/filings/0001437749-26-026460.md) |
| Gross profit | $m | not reported | not reported | [16.4](/filings/0001437749-25-015691.md) | [16.3](/filings/0001437749-25-025595.md) | [16.2](/filings/0001437749-25-033742.md) | [16.8 d](/filings/0001437749-26-008073.md) | [17.4](/filings/0001437749-25-015691.md) | [19.9](/filings/0001437749-25-025595.md) | [18.2](/filings/0001437749-25-033742.md) | [18.0 d](/filings/0001437749-26-008073.md) | not reported | not reported |
| Selling, general and administrative | $m | [0.3](/filings/0001437749-24-034841.md) | [0.2 d](/filings/0001437749-26-008073.md) | [0.2](/filings/0001437749-25-015691.md) | [0.2](/filings/0001437749-25-025595.md) | [0.2](/filings/0001437749-25-033742.md) | [0.2 d](/filings/0001437749-26-008073.md) | [0.2](/filings/0001437749-26-015780.md) | [0.3](/filings/0001437749-26-026460.md) | [0.3](/filings/0001437749-25-033742.md) | [0.2 d](/filings/0001437749-26-008073.md) | [0.2](/filings/0001437749-26-015780.md) | [0.2](/filings/0001437749-26-026460.md) |
| Interest expense | $m | [13.1](/filings/0001437749-23-031495.md) | [16.1 d](/filings/0001437749-24-008676.md) | [17.0](/filings/0001437749-24-016165.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [1.5](/filings/0001437749-24-034841.md) | [1.1 d](/filings/0001437749-26-008073.md) | [0.8](/filings/0001437749-25-015691.md) | [0.2](/filings/0001437749-25-025595.md) | [(0.2)](/filings/0001437749-25-033742.md) | [(4.8) d](/filings/0001437749-26-008073.md) | [0.7](/filings/0001437749-26-015780.md) | [1.1](/filings/0001437749-26-026460.md) | [0.9](/filings/0001437749-25-033742.md) | [0.8 d](/filings/0001437749-26-008073.md) | [1.3](/filings/0001437749-26-015780.md) | [1.4](/filings/0001437749-26-026460.md) |
| Net income | $m | [6.3](/filings/0001437749-24-034841.md) | [5.1 d](/filings/0001437749-26-008073.md) | [3.3](/filings/0001437749-25-015691.md) | [2.6](/filings/0001437749-25-025595.md) | [0.3](/filings/0001437749-25-033742.md) | [(16.2) d](/filings/0001437749-26-008073.md) | [2.5](/filings/0001437749-26-015780.md) | [4.6](/filings/0001437749-26-026460.md) | [4.5](/filings/0001437749-25-033742.md) | [4.1 d](/filings/0001437749-26-008073.md) | [4.1](/filings/0001437749-26-015780.md) | [4.7](/filings/0001437749-26-026460.md) |
| Diluted EPS | $ per share | [0.77](/filings/0001437749-24-034841.md) | not reported | [0.36](/filings/0001437749-25-015691.md) | [0.27](/filings/0001437749-25-025595.md) | [(0.04)](/filings/0001437749-25-033742.md) | not reported | [0.25](/filings/0001437749-26-015780.md) | [0.53](/filings/0001437749-26-026460.md) | [0.52](/filings/0001437749-25-033742.md) | not reported | [0.48](/filings/0001437749-26-015780.md) | [0.58](/filings/0001437749-26-026460.md) |
| Basic EPS | $ per share | [0.77](/filings/0001437749-24-034841.md) | not reported | [0.36](/filings/0001437749-25-015691.md) | [0.27](/filings/0001437749-25-025595.md) | [(0.04)](/filings/0001437749-25-033742.md) | not reported | [0.25](/filings/0001437749-26-015780.md) | [0.53](/filings/0001437749-26-026460.md) | [0.52](/filings/0001437749-25-033742.md) | not reported | [0.48](/filings/0001437749-26-015780.md) | [0.58](/filings/0001437749-26-026460.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Total assets | $m | [2,021](/filings/0001437749-24-034841.md) | [2,035](/filings/0001437749-26-008073.md) | [2,070](/filings/0001437749-25-015691.md) | [2,094](/filings/0001437749-25-025595.md) | [2,225](/filings/0001437749-25-033742.md) | [2,228](/filings/0001437749-26-008073.md) | [2,223](/filings/0001437749-25-015691.md) | [2,115](/filings/0001437749-25-025595.md) | [2,125](/filings/0001437749-25-033742.md) | [2,213](/filings/0001437749-26-026460.md) | [2,223](/filings/0001437749-26-015780.md) | [2,243](/filings/0001437749-26-026460.md) |
| Total liabilities | $m | [1,808](/filings/0001437749-23-031495.md) | [1,814](/filings/0001437749-26-007948.md) | [1,847](/filings/0001437749-24-016165.md) | [1,869](/filings/0001437749-24-026291.md) | [1,999](/filings/0001437749-24-034841.md) | [2,020](/filings/0001437749-26-008073.md) | [2,013](/filings/0001437749-25-015691.md) | [1,901](/filings/0001437749-25-025595.md) | [1,906](/filings/0001437749-25-033742.md) | [1,994](/filings/0001437749-26-026460.md) | [2,008](/filings/0001437749-26-015780.md) | [2,029](/filings/0001437749-26-026460.md) |
| Shareholders' equity | $m | [214](/filings/0001437749-24-034841.md) | [222](/filings/0001437749-26-008073.md) | [223](/filings/0001437749-25-025595.md) | [225](/filings/0001437749-25-033742.md) | [226](/filings/0001437749-25-033742.md) | [208](/filings/0001437749-26-026460.md) | [210](/filings/0001437749-26-026460.md) | [213](/filings/0001437749-26-026460.md) | [218](/filings/0001437749-25-033742.md) | [219](/filings/0001437749-26-026460.md) | [215](/filings/0001437749-26-026460.md) | [214](/filings/0001437749-26-026460.md) |

- Cash and equivalents: not reported
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [9,628 d](/filings/0001437749-24-034841.md) | [5,325 d](/filings/0001437749-26-008073.md) | [3,643](/filings/0001437749-25-015691.md) | [1,174 d](/filings/0001437749-25-025595.md) | [4,470 d](/filings/0001437749-25-033742.md) | [5,453 d](/filings/0001437749-26-008073.md) | [1,451](/filings/0001437749-26-015780.md) | [1,194 d](/filings/0001437749-26-026460.md) | [5,589 d](/filings/0001437749-25-033742.md) | [6,577 d](/filings/0001437749-26-008073.md) | [6,603](/filings/0001437749-26-015780.md) | [4,945 d](/filings/0001437749-26-026460.md) |
| Capital expenditure | $k | [155 d](/filings/0001437749-24-034841.md) | [7.0 d](/filings/0001437749-26-008073.md) | [607](/filings/0001437749-25-015691.md) | [102 d](/filings/0001437749-25-025595.md) | [161 d](/filings/0001437749-25-033742.md) | [39.0 d](/filings/0001437749-26-008073.md) | [55.0](/filings/0001437749-26-015780.md) | [3,822 d](/filings/0001437749-26-026460.md) | [138 d](/filings/0001437749-25-033742.md) | [159 d](/filings/0001437749-26-008073.md) | [101](/filings/0001437749-26-015780.md) | [96.0 d](/filings/0001437749-26-026460.md) |
| Dividends paid | $k | [753 d](/filings/0001437749-24-034841.md) | [753 d](/filings/0001437749-26-008073.md) | [764](/filings/0001437749-25-015691.md) | [762 d](/filings/0001437749-25-025595.md) | [760 d](/filings/0001437749-25-033742.md) | [760 d](/filings/0001437749-26-008073.md) | [759](/filings/0001437749-26-015780.md) | [771 d](/filings/0001437749-26-026460.md) | [770 d](/filings/0001437749-25-033742.md) | [750 d](/filings/0001437749-26-008073.md) | [758](/filings/0001437749-26-015780.md) | [712 d](/filings/0001437749-26-026460.md) |
| Share repurchases | $k | [0.0 d](/filings/0001437749-24-034841.md) | [0.0 d](/filings/0001437749-26-008073.md) | [419](/filings/0001437749-25-015691.md) | [300 d](/filings/0001437749-25-025595.md) | [0.0 d](/filings/0001437749-25-033742.md) | [13.0 d](/filings/0001437749-26-008073.md) | [446](/filings/0001437749-26-015780.md) | [0.0 d](/filings/0001437749-26-026460.md) | [0.0 d](/filings/0001437749-25-033742.md) | [3,890 d](/filings/0001437749-26-008073.md) | [6,080](/filings/0001437749-26-015780.md) | [4,986 d](/filings/0001437749-26-026460.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

Shares outstanding: 7,121,076 at 2026-07-31, from the cover of the [10-Q filed 2026-08-07](/filings/0001437749-26-026460.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:46 ET. No prices; not investment advice.